IUCRO-0498; Role of Osteocytes in Myeloma Bone Disease

Study Overview

The purpose of this study is to learn if substances that may cause bone destruction are increased in blood or bone marrow.

Study Description

The investigators hope to determine serum FGF23 and heparanase, Dkk1 and plasma klotho levels in patients with newly diagnosed and relapsed myeloma compared to healthy controls with this exploratory study.

Additional Information:

Participants will not be paid for their participation.

Research Study Identifier: TX4046
ClinicalTrials.gov Identifier: NCT1407589587
Principal Investigator: Attaya Suvannasankha, MD

Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.